FDA Approves Clinical Trial of Psilocybin for Depression
Aug 28, 2018 13:39:13 GMT
sgard434, miamianne67, and 2 more like this
Post by icemandios on Aug 28, 2018 13:39:13 GMT
FDA approves 'magic mushroom' psilocybin therapy trial for treatment-resistant depression
23-Aug-2018 By Maggie Lynch
Compass Pathways has received approval from the US FDA for a clinical trial using psilocybin, the active ingredient in âmagic mushrooms.â
www.in-pharmatechnologist.com/Article/2018/08/23/FDA-approves-psychoactive-psilocybin-therapy-trial-for-treatment-resistant-depression
23-Aug-2018 By Maggie Lynch
Compass Pathways has received approval from the US FDA for a clinical trial using psilocybin, the active ingredient in âmagic mushrooms.â
www.in-pharmatechnologist.com/Article/2018/08/23/FDA-approves-psychoactive-psilocybin-therapy-trial-for-treatment-resistant-depression